Related Experiment Video
Updated: Nov 4, 2025

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Differences in Levodopa Response for Progressive and Non-Progressive Micrographia in Parkinson's Disease
Poonam Zham1,2, Sridhar A Poosapadi1,3, Peter Kempster4,5
1School of Engineering, RMIT University, Melbourne, VIC, Australia.
Abstract:
Background: Micrographia, one element of the dysgraphia of Parkinson's disease (PD), may be classified according to the presence or absence of a decremental pattern. The decremental form, progressive micrographia, is an expression of the sequence effect seen generally in bradykinesia. Its responsiveness to levodopa has not been evaluated kinematically. Objectives: Aim of this study is to investigate the difference in levodopa response for progressive and non-progressive micrographia. Methods: Twenty-four PD patients and 24 age-matched repeatedly wrote the letter e on a computerized digital tablet. PD patients performed the task two times, in a defined off state and again after levodopa. Scripts were classified as progressive micrographia (PDPM) or non-progressive micrographia (PDNPM) depending on whether a 10% decrement was seen between the first and final characters of a line of lettering. Results: While levodopa produced a similar response on the MDS-UPDRS motor scale for the two groups, the effect on the two types of micrographia was different. While writing speed improved significantly in both groups after levodopa, the responses were over twofold greater for PDNPM. Moreover, the decremental features of PDPM-in size, speed, and pen-pressure-were largely unaltered by a levodopa dose. Conclusions: Progressive micrographia is less responsive to levodopa. Our findings agree with research showing that the sequence effect of bradykinesia is relatively resistant to medication. Yet we did not find a weaker overall levodopa motor benefit. Caution is needed in the interpretation of such micrographia measurements for estimating drug responses.
Insights
Progressive micrographia in Parkinson's disease (PD) shows less improvement with levodopa treatment compared to non-progressive micrographia. Kinematic analysis reveals distinct drug responses for these PD subtypes.
Area of Science:
- Neurology
- Movement Disorders
- Pharmacology
Background:
- Micrographia is a common writing impairment in Parkinson's disease (PD).
- It can be classified as progressive (with a decremental pattern) or non-progressive.
- The kinematic response of progressive micrographia to levodopa is not well understood.
Purpose of the Study:
- To investigate and compare the kinematic response to levodopa in progressive micrographia (PD_PM) versus non-progressive micrographia (PD_NPM) in Parkinson's disease patients.
Main Methods:
- Twenty-four PD patients performed repeated writing tasks on a digital tablet in both an 'off' state and after levodopa administration.
- Scripts were analyzed to classify patients into PD_PM or PD_NPM based on a 10% decrement in writing features.
- Levodopa's effect was assessed using MDS-UPDRS motor scores and kinematic writing parameters.
Main Results:
- Levodopa improved writing speed in both PD_PM and PD_NPM groups, but the improvement was more than twofold greater in the PD_NPM group.
- Key decremental features (size, speed, pen pressure) in PD_PM were largely unaffected by levodopa.
- Both groups showed similar motor improvements on the MDS-UPDRS scale.
Conclusions:
- Progressive micrographia exhibits reduced responsiveness to levodopa compared to non-progressive micrographia.
- These findings suggest that the sequence effect in PD bradykinesia may be relatively resistant to levodopa.
- Careful interpretation of micrographia measurements is advised when assessing drug efficacy in PD.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Neural Regulation

